<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="3091" end="3095" sStart="2912" offset="179" sid="r11.true.j.0562" wn="7" wnkey="true%5:00:00:sincere:00" annotator="vebatchelder" text="1. For the clearest interpretation, statistics for binary markers should be based on true and false positive rates or predictive values based on the true prevalence - not odds ratios, relative risks, or predictive values based on the prevalence in the study " />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="3703" end="3707" sStart="null" offset="4" sid="r11.true.j.0484" wn="1" wnkey="true%3:00:00::" annotator="vebatchelder" text="The true positive rate (TPR), or the test sensitivity, is the probability the marker is positive given cancer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="8188" end="8198" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" annotator="cgozo" text="The less restricted definition is the probability of a &lt;b&gt;suspicious&lt;/b&gt; mammogram warranting additional diagnostic follow-up of any type in women without cancer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="8188" end="8198" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" annotator="cgozo" text="The less restricted definition is the probability of a &lt;b&gt;suspicious&lt;/b&gt; mammogram warranting additional diagnostic follow-up of any type in women without cancer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="8188" end="8198" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" annotator="brubin" text="The less restricted definition is the probability of a &lt;b&gt;suspicious&lt;/b&gt; mammogram warranting additional diagnostic follow-up of any type in women without cancer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="8188" end="8198" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" annotator="brubin" text="The less restricted definition is the probability of a &lt;b&gt;suspicious&lt;/b&gt; mammogram warranting additional diagnostic follow-up of any type in women without cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="12583" end="12589" sStart="null" offset="165" sid="r11.severe.j.0063" wn="1" wnkey="severe%5:00:00:intense:00" annotator="anfahmy" text="Some markers, such as sputum cytology, inherently involve ordered categories, such as no evidence of cancer, slight atypia, moderate atypia, severe atypia, and frank cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="12583" end="12589" sStart="null" offset="165" sid="r11.severe.j.0063" wn="6" wnkey="severe%5:00:01:bad:00" annotator="adelpriore" text="Some markers, such as sputum cytology, inherently involve ordered categories, such as no evidence of cancer, slight atypia, moderate atypia, severe atypia, and frank cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="4725" end="4734" sStart="null" offset="223" sid="r11.recommend.v.0431" wn="1" wnkey="recommend%2:32:01::" annotator="anfahmy" text="Because the underlying prevalence of cancer is so low in average risk populations, for acceptable cancer screening of asymptomatic people, the FPR should be very small [ 9 ] . As a starting point we recommend basing guidelines for FPR and TPR on the FPR and TPR for mammography, which, as discussed below, is FPR=." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21171" end="21175" sStart="null" offset="161" sid="r7.poor.j.0649" wn="4" wnkey="poor%3:00:02::" annotator="veweser" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="4372" end="4376" sStart="null" offset="20" sid="r7.poor.j.0501" wn="4" wnkey="poor%3:00:02::" annotator="veweser" text="But this would be a poor classification rule because the FPR would also be 1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21171" end="21175" sStart="null" offset="161" sid="r7.poor.j.0649" wn="4" wnkey="poor%3:00:02::" annotator="jeneale" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="4372" end="4376" sStart="null" offset="20" sid="r7.poor.j.0501" wn="4" wnkey="poor%3:00:02::" annotator="jeneale" text="But this would be a poor classification rule because the FPR would also be 1." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23690" end="23696" sStart="null" offset="0" sid="null" wn="1" wnkey="player%1:18:01::" annotator="veweser" text="As a simple example, overfitting occurs when a sports announcer reports that a baseball &lt;b&gt;player&lt;/b&gt; had a very high batting average against left-handed pitchers in ballpark X over the past month." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23690" end="23696" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" annotator="tofox" text="As a simple example, overfitting occurs when a sports announcer reports that a baseball &lt;b&gt;player&lt;/b&gt; had a very high batting average against left-handed pitchers in ballpark X over the past month." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="28027" end="28033" sStart="null" offset="8" sid="r9.normal.j.0317" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Using a normal approximation the target standard error is approximately .05." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="6121" end="6125" sStart="null" offset="228" sid="r8.life.n.0236" wn="5" wnkey="life%1:28:00::" annotator="cgozo" text="Importantly the estimated TPR for mammography is not likely to be affected by overdiagnosis, which means that some screening-detected cancers would never have caused medical problems during the patient's life [ 11 ] . This would make the biomarker appear more promising than actually the case." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="3271" end="3275" sStart="null" offset="33" sid="r10.high.j.0387" wn="1" wnkey="high%3:00:02::" annotator="cgozo" text="A promising marker should have a high degree of accuracy in discriminating between subjects who are likely to get cancer from those who are not." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="24019" end="24023" sStart="null" offset="15" sid="r10.high.j.0524" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="In reality the high average is more likely the result of chance factors that coincided with left handed pitchers at ballpark X during that particular month." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21778" end="21787" sStart="null" offset="40" sid="r8.1.different.j.0513" wn="4" wnkey="different%5:00:01:other:00" annotator="veweser" text="With marker measurements at two different times per subject (and approximately the same interval between times), a common summary measure is the slope." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="15954" end="15961" sStart="null" offset="65" sid="r10.control.n.0217" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="It would not always be possible to identify all relevant control conditions, but to the extent possible, the control conditions should be similar in both populations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="16006" end="16013" sStart="null" offset="117" sid="r10.control.n.0280" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="It would not always be possible to identify all relevant control conditions, but to the extent possible, the control conditions should be similar in both populations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="1725" end="1733" sStart="null" offset="137" sid="r10.control.n.0256" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="In a subsequent nested case-control study, stored serum samples from all cases of prostate cancer and a random sample of controls were tested for prostate-specific antigen (PSA)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21869" end="21875" sStart="null" offset="131" sid="r10.common.j.0463" wn="3" wnkey="common%5:00:00:shared:00" annotator="cgozo" text="With marker measurements at two different times per subject (and approximately the same interval between times), a common summary measure is the slope." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="9431" end="9437" sStart="null" offset="132" sid="r10.common.j.0974" wn="2" wnkey="common%3:00:01::" annotator="anfahmy" text="When evaluating binary early detection markers, it is inappropriate to report an odds ratio or relative risk, as is common in epidemiology or clinical trials." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21064" end="21075" sStart="null" offset="54" sid="null" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="24796" end="24808" sStart="null" offset="17" sid="r11.combination.n.0916" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="Promising marker combinations are identified in the training sample, but more reliable FPR and TPR measurements are made in the test sample because it involves different data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21064" end="21075" sStart="null" offset="54" sid="r11.combination.n.0640" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="18988" end="18999" sStart="null" offset="29" sid="r11.combination.n.0355" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="Creating an ROC curve from a combination of markers is different from creating an ROC curve from a single marker." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="20711" end="20723" sStart="null" offset="204" sid="r11.combination.n.0172" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="Alternative approaches that do not directly optimize the ROC curve include linear logistic regression or linear discriminant analysis [ 17 ] , which choose regions based on linear combinations of the markers, and neural networks [ 18 ] , which choose regions in a very complicated nonlinear manner." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21064" end="21075" sStart="null" offset="54" sid="null" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="18867" end="18878" sStart="null" offset="43" sid="r11.combination.n.0953" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="To more generally compare performance of a combination of markers with a single marker, we need to compare ROC curves." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21064" end="21075" sStart="null" offset="54" sid="null" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting chance patterns in the first sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23204" end="23216" sStart="null" offset="26" sid="r11.combination.n.0819" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="However with many combinations of markers, overfitting could invalidate results." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="18662" end="18673" sStart="null" offset="40" sid="r11.combination.n.0813" wn="7" wnkey="combination%1:04:00::" annotator="adelpriore" text="Thus, in this real example, the combination of markers led to a better test than the separate markers, with a larger TPR (.92 versus .78 or .32) for the same FPR of .02." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="20174" end="20185" sStart="null" offset="72" sid="r11.combination.n.0696" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="Mathematically, in any sample of data, the best ROC curve for a combination of markers must be as good or better than the ROC curve for any of the markers evaluated separately." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="17284" end="17295" sStart="null" offset="46" sid="r11.combination.n.0651" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="Thus, in this particular example, the combination of markers leads to a much better test than the separate markers, with a smaller FPR (.04 versus .20) for the same TPR of .80." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="20372" end="20383" sStart="null" offset="69" sid="r11.combination.n.0534" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="The reason is that the set of possible regions for calling a combination of markers positive includes as a special case the regions for calling any single marker positive." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="17713" end="17725" sStart="null" offset="33" sid="r11.combination.n.0441" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="A real application of how marker combinations provide extra information comes from a recent study by Mok et al [ 15 ] on CA125 and Prostasin as markers for ovarian cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="19096" end="19107" sStart="null" offset="7" sid="r11.combination.n.0234" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="With a combination of markers, the number of possible regions, as in Table 3a, for calling a marker positive is extremely large." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="22010" end="22021" sStart="null" offset="96" sid="r11.combination.n.0156" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="If investigators believe that both slope and baseline level predict cancer, the combination can be evaluated using the previously discussed methods for evaluating multiple markers, namely, treating baseline level and slope as two &quot;separate&quot; markers." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="24069" end="24075" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="veweser" text="In reality the high average is more likely the result of &lt;b&gt;chance&lt;/b&gt; factors that coincided with left handed pitchers at ballpark X during that particular month." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23553" end="23559" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="Overfitting of a larger number of markers to a relatively small number of subjects produces a model that is overly sensitive to &lt;b&gt;chance&lt;/b&gt; fluctuations in the data." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21256" end="21262" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting &lt;b&gt;chance&lt;/b&gt; patterns in the first sample." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23553" end="23559" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="comcgeetubb" text="Overfitting of a larger number of markers to a relatively small number of subjects produces a model that is overly sensitive to &lt;b&gt;chance&lt;/b&gt; fluctuations in the data." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21256" end="21262" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="comcgeetubb" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting &lt;b&gt;chance&lt;/b&gt; patterns in the first sample." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="23553" end="23559" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="Overfitting of a larger number of markers to a relatively small number of subjects produces a model that is overly sensitive to &lt;b&gt;chance&lt;/b&gt; fluctuations in the data." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="21256" end="21262" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="If one takes the set of regions for calling a combination positive that gives a good ROC curve in a random sample of data, it may give a poor ROC curve in another random sample of the data, simply due to selecting &lt;b&gt;chance&lt;/b&gt; patterns in the first sample." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="24069" end="24075" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" annotator="carichter" text="In reality the high average is more likely the result of &lt;b&gt;chance&lt;/b&gt; factors that coincided with left handed pitchers at ballpark X during that particular month." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-2-4.anc" start="6173" end="6179" sStart="null" offset="280" sid="r9.appear.v.0958" wn="1" wnkey="appear%2:39:00::" annotator="anfahmy" text="Importantly the estimated TPR for mammography is not likely to be affected by overdiagnosis, which means that some screening-detected cancers would never have caused medical problems during the patient's life [ 11 ] . This would make the biomarker appear more promising than actually the case." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-2-4.anc" start="10924" end="10928" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" annotator="tofox" text="Because the likelihood of any individual cancer type in an asymptomatic person is nearly always very low, a negative early detection test usually &lt;b&gt;adds&lt;/b&gt; little information to the clinical impression." />
  </sentences>
</list>